An excess of glucocorticoids has been associated with hippocampal pathology in major depressive disorder (MDD). However, the relationships between depression, hippocampal structure and function, and cortisol levels are unclear, and the effects of antidepressant treatment on the measures are not well studied. For this study, 26 first-episode, treatment-naive, non-late-life adult depressed patients and 13 healthy controls were enrolled. Subjects underwent proton magnetic resonance spectroscopy (1H MRS) to obtain metabolite levels from the bilateral hippocampus. Patients with MDD were treated with serotonergic–noradrenergic reuptake inhibitor duloxetine for 12 weeks. After the 12-week period, all subjects with MDD underwent 1H MRS again. Morning serum cortisol levels also were measured both before and after antidepressant treatment. Comparison of baseline values indicated that there were no significant differences in any of the metabolite ratios (N-acetyl aspartate/creatine (NAA/Cr) and choline (Cho)/Cr) in the bilateral hippocampus. After treatment, NAA/Cr ratios increased significantly in the right hippocampus compared with pre-treatment values. There was no correlation between morning serum cortisol levels and bilateral hippocampal NAA/Cr or Cho/Cr in patients with MDD. These findings suggest that there are unaltered hippocampal metabolites in the early stage of MDD. Antidepressant treatment may affect hippocampal NAA levels in patients with MDD. In addition, the results do not support cortisol-mediated hippocampal neurotoxicity as the major etiological mechanism.
AuerDPPützBKraftE. (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry47: 305–313.
2.
AxelsonDADoraiswamyPMMcDonaldWM. (1993) Hypercortisolemia and hippocampal changes in depression. Psychiatry Res47: 163–173.
3.
BanasrMDwyerJMDumanRS (2011) Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol23: 730–737.
4.
BellaniMDusiNYehPH. (2011) The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression. Progr Neuropsychopharmacol Biol Psychiatry35: 1544–1552.
5.
BhakooKKPearceD (2000) In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem74: 254–262.
6.
BlockWTraberFvon WiddernO. (2009) Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol12: 415–422.
7.
BoldriniMUnderwoodMDHenR. (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology34: 2376–2389.
8.
CapizzanoAAJorgeREAcionLC. (2007) In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review. J Magn Reson Imaging26: 1378–1389.
9.
CaseyPMaracyMKellyBD. (2006) Can adjustment disorder and depressive episode be distinguished? Results from ODIN. J Affect Disord92: 291–297.
10.
CollaMKronenbergGDeuschleM. (2007) Hippocampal volume reduction and HPA-system activity in major depression. J Psychiatr Res41: 553–560.
11.
CollaMSchubertFBubnerM. (2009) Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol Psychiatry14: 696–704.
12.
CouplandNJOgilvieCJHegadorenKM. (2005) Decreased prefrontal myo-inositol in major depressive disorder. Biol Psychiatry57: 1526–1534.
13.
CrochemoreCLuJWuY. (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry10: 790–798.
14.
CzehBMichaelisTWatanabeT. (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A98: 12796–12801.
15.
EkerCGonulAS (2010) Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research. World J Biol Psychiatry11: 19–35.
16.
EkerCKitisOTaneliF. (2010) Correlation of serum BDNF levels with hippocampal volumes in first episode, medication-free depressed patients. Eur Arch Psychiatry Clin Neurosci260: 527–533.
17.
EndeGDemirakcaTWalterS. (2007) Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression. Eur Arch Psychiatry Clin Neurosci257: 36–39.
18.
EndeGHennFABrausDF. (2000) The hippocampus in patients treated with electroconvulsive therapy – A proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry57: 937–943.
19.
FarchioneTRMooreGJRosenbergDR (2002) Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry52: 86–92.
20.
FrodlTJagerMSmajstrlovaI. (2008) Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci33: 423–430.
21.
GonulASKitisOOzanE. (2006) The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry30: 120–125.
22.
GruberSFreyRMlynarikV. (2003) Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol38: 403–408.
23.
HuangYChenWLiY. (2010) Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: A study using 1H magnetic resonance spectroscopy. Psychiatry Res182: 48–52.
24.
JacobsBLvan PraagHGageFH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry5: 262–269.
25.
KaymakSUDemirBOguzKK. (2009) Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naive female patients with first-episode major depression. Psychiatry Clin Neurosci63: 350–356.
26.
KennedySHEvansKRKrugerS. (2001) Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry158: 899–905.
27.
KoolschijnPCvan HarenNELensvelt-MuldersGJ. (2009) Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp30: 3719–3735.
28.
KrishnanVNestlerEJ (2008) The molecular neurobiology of depression. Nature455: 894–902.
29.
KumarAThomasALavretskyH. (2002) Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry159: 630–636.
30.
KusumakarVMacMasterFPGatesL. (2001) Left medial temporal cytosolic choline in early onset depression. Can J Psychiatry46: 959–964.
31.
LupienSJde LeonMde SantiS. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci1: 69–73.
32.
MagarinosAMDeslandesAMcEwenBS (1999) Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol371: 113–122.
33.
MalbergJEEischAJNestlerEJ. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci20: 9104–9110.
34.
MalykhinNVCarterRSeresP. (2010) Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci35: 337–343.
35.
ManevHUzTSmalheiserNR. (2001) Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol411: 67–70.
36.
McLaughlinKJGomezJLBaranSE. (2007) The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms. Brain Res1161: 56–64.
37.
MervaalaEFohrJKononenM. (2000) Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med30: 117–125.
38.
MichaelNErfurthAOhrmannP. (2003) Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology28: 720–725.
39.
MilneAMacQueenGMYucelK. (2009) Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: A proton magnetic resonance spectroscopy study. Neuroimage47: 36–41.
40.
MirzaYTangJRussellA. (2004) Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry43: 341–348.
41.
MooreGJBebchukJMHasanatK. (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?Biol Psychiatry48: 1–8.
42.
NestlerEJBarrotMDiLeoneRJ. (2002) Neurobiology of depression. Neuron34: 13–25.
43.
NeylanTCSchuffNLenociM. (2003) Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry54: 1118–1121.
44.
O’BrienJTLloydAMcKeithI. (2004) A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry161: 2081–2090.
45.
OlveraRLCaetanoSCStanleyJA. (2010) Reduced medial prefrontal N-Acetyl-Aspartate levels in pediatric major depressive disorder: A multi-voxel in vivo1H spectroscopy study. Psychiatry Res184: 71–76.
46.
PereraTDCoplanJDLisanbySH. (2007) Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci27: 4894–4901.
47.
RajkowskaG (2003) Depression: What we can learn from postmortem studies. Neuroscientist9: 273–284.
48.
RavnkildeBVidebechPClemmensenK. (2002) Cognitive deficits in major depression. Scand J Psychol43: 239–251.
49.
SalaMPerezJSoloffP. (2004) Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol14: 393–405.
50.
SapolskyRM (2000a) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry57: 925–935.
51.
SapolskyRM (2000b) The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry48: 755–765.
52.
SaxenaSBrodyALHoML. (2001) Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry50: 159–170.
53.
SteingardRJYurgelun-ToddDAHennenJ. (2000) Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry48: 1053–1061.
54.
StockmeierCAMahajanGJKonickLC. (2004) Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry56: 640–650.
55.
TaylorMMurphySESelvarajS. (2008) Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. J Psychopharmacol22: 473–476.
56.
UrenjakJWilliamsSRGadianDG. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci13: 981–989.
57.
VidebechPRavnkildeB (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry161: 1957–1966.
58.
VidebechPRavnkildeBPedersenTH. (2002) The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand106: 35–44.
59.
VythilingamMCharlesHCTuplerLA. (2003) Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: An automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry54: 744–750.
60.
VythilingamMVermettenEAndersonGM. (2004) Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry56: 101–112.
61.
WangJWDavidDJMoncktonJE. (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci28: 1374–1384.
62.
World Health Organization (2001) The World Health Report: 2001. Mental Health: New Understanding, New Hope: World Health Organization.
63.
YauJLWHibberdCNobleJ. (2002) The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Mol Brain Res106: 117–123.
64.
Yildiz-YesilogluAAnkerstDP (2006) Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res147: 1–25.
